Skip to content
HowShorted

KALA BIO, Inc. short interest in 2020

In 2020, KALA BIO, Inc.'s disclosed short interest ran from 15.18% of shares outstanding on 15 Jan 2020 to 16.84% on 31 Dec 2020, a change of +1.66 percentage points. The year's high was 19.02% on 13 Mar 2020 and its low 6.45% on 15 Jun 2020, averaging 12.22% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 9.24 days on 14 Feb 2020. Full history: KALA BIO, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for KALA BIO, Inc. in 2020

2020 in figures

Start of year
15.18% (15 Jan 2020)
End of year
16.84% (31 Dec 2020)
Change
+1.66 pp
High
19.02% (13 Mar 2020)
Low
6.45% (15 Jun 2020)
Average
12.22%
Highest days to cover
9.24 (14 Feb 2020)
SEC filings marked
10

Every report in 2020

KALA BIO, Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 202015.18%5.30results (8-K)
31 Jan 202015.33%5.77
14 Feb 202014.59%9.2410-K filed, results (8-K)
28 Feb 202014.85%8.24
13 Mar 202019.02%2.99
31 Mar 202016.74%3.67
15 Apr 202013.48%4.27
30 Apr 202013.13%5.47
15 May 20207.14%3.6310-Q filed, results (8-K)
29 May 20206.71%4.64
15 Jun 20206.45%4.05
30 Jun 20209.32%4.20
15 Jul 20209.58%7.77
31 Jul 20209.71%7.03
14 Aug 20207.66%6.6410-Q filed, results (8-K)
31 Aug 202010.35%8.04
15 Sep 202010.99%6.15
30 Sep 202011.64%5.83
15 Oct 202010.91%4.64
30 Oct 202014.68%3.84results (8-K)
13 Nov 202012.42%6.1910-Q filed, results (8-K)
30 Nov 202012.14%6.90
15 Dec 202014.45%5.45
31 Dec 202016.84%4.15

See also: KALA BIO, Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.